FDA Adverse Event Injury Summary report: N

CYTOPLAST PTFE SUTURE

MDR report key: 11475115 · Received March 12, 2021

Report

Report Number
1650372-2021-00002
Event Type
Injury
Date Received
March 12, 2021
Report Date
March 10, 2021
Manufacturer
OSTEOGENICS BIOMEDICAL, INC.
Product Code
NBY
UDI-DI
D765CS0618PREM0
PMA / PMN Number
K072076
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 1

THE UNITS WERE NOT RETURNED, SO THEY COULD NOT BE INSPECTED. THE LOT HISTORY WAS REVIEWED AND THE PRODUCT WAS VERIFIED TO HAVE BEEN MANUFACTURED CORRECTLY AND STERILIZED VIA A VALIDATED STERILIZATION CYCLE, AND NO DISCREPANCIES WERE FOUND. PTFE IS A BIOINERT MATERIAL AND THIS IS THE FIRST COMPLAINT RECEIVED BY OSTEOGENICS CONCERNING TISSUE IRRITATION/SWELLING. THERE ARE MANY CLINICAL FACTORS THAT COULD LEAD TO THIS EVENT, AND BASED ON THE REVIEW OF THE LOT HISTORY AND COMPLAINT TRENDING, WE DO NOT BELIEVE THIS WAS DEVICE RELATED.

Description of Event or Problem · 1

THE CLINICIAN STATED THAT THE TISSUE AROUND THE PTFE SUTURE BECAME SWOLLEN AND THEREFORE HAD A HIGHER TENSION ON THE FLAP. THE SUTURE HAD TO BE REMOVED EARLY AND UPON REMOVAL THE IRRITATION DISAPPEARED. THE PATIENT HEALED UPON SUTURE REMOVAL AND THEREFORE THERE WAS NO SERIOUS OUTCOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
370261 CYTOPLAST PTFE SUTURE PTFE SUTURE NBY OSTEOGENICS BIOMEDICAL, INC. CS0618PREM RC06435A D765CS0618PREM0

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention